Increased expression of Cathepsin B in oral squamous cell carcinoma
- PMID: 20042316
- DOI: 10.1016/j.ijom.2009.11.018
Increased expression of Cathepsin B in oral squamous cell carcinoma
Abstract
Previously, an in vitro cellular carcinogenesis model of oral squamous cell carcinoma (OSCC) was established with a line of human immortalized oral epithelial cells (HIOECs), a line of cancerous HB96 cells and another type of cell (HB56 cells) at the early stage of carcinogenesis. In this study, comparative proteomic analysis identified a panel of differentially expressed proteins among these cells. Cathepsin B was one of the significantly up-regulated proteins accompanying cellular transformation. Cathepsin B was further validated for its expression in the three cell lines and in clinical samples of tumour tissues and their adjacent normal epithelia from 30 primary OSCC patients. Western blot analysis and real-time PCR detected increased Cathepsin B protein and mRNA levels in the cancerous HB56 and HB96 cells over HIOECs. Immunohistochemistry and real-time PCR showed elevated Cathepsin B protein and mRNA levels in the tumour tissues over the adjacent non-malignant epithelia from OSCC patients. The results presented here suggest that the expression of Cathepsin B increases along with the cancerisation in OSCC both in vitro and in vivo, and it may serve as a candidate biomarker of OSCC.
Copyright 2009 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Increased expression of Annexin A2 in oral squamous cell carcinoma.Arch Oral Biol. 2009 Jan;54(1):17-25. doi: 10.1016/j.archoralbio.2008.08.006. Epub 2008 Sep 25. Arch Oral Biol. 2009. PMID: 18822406
-
Decreased expression of Annexin A1 correlates with pathologic differentiation grade in oral squamous cell carcinoma.J Oral Pathol Med. 2009 Apr;38(4):362-70. doi: 10.1111/j.1600-0714.2008.00678.x. Epub 2008 Jul 31. J Oral Pathol Med. 2009. PMID: 18673418
-
Overexpression of cytokeratin 17 protein in oral squamous cell carcinoma in vitro and in vivo.Oral Dis. 2009 Jan;15(1):111-7. doi: 10.1111/j.1601-0825.2008.01501.x. Epub 2008 Nov 3. Oral Dis. 2009. PMID: 18992022
-
Cancer stem cells and field cancerization of oral squamous cell carcinoma.Oral Oncol. 2015 Jul;51(7):643-51. doi: 10.1016/j.oraloncology.2015.04.006. Epub 2015 Apr 23. Oral Oncol. 2015. PMID: 25920765 Review.
-
Role of Cathepsin B Expression in Oral Squamous Cell Carcinoma: A Comprehensive Review.Cureus. 2024 Feb 15;16(2):e54267. doi: 10.7759/cureus.54267. eCollection 2024 Feb. Cureus. 2024. PMID: 38500921 Free PMC article. Review.
Cited by
-
Circumventing AKT-Associated Radioresistance in Oral Cancer by Novel Nanoparticle-Encapsulated Capivasertib.Cells. 2020 Feb 25;9(3):533. doi: 10.3390/cells9030533. Cells. 2020. PMID: 32106632 Free PMC article.
-
Expression of stefin A is of prognostic significance in squamous cell carcinoma of the head and neck.Eur Arch Otorhinolaryngol. 2013 Nov;270(12):3143-51. doi: 10.1007/s00405-013-2465-5. Epub 2013 Apr 2. Eur Arch Otorhinolaryngol. 2013. PMID: 23545885
-
Combating head and neck cancer metastases by targeting Src using multifunctional nanoparticle-based saracatinib.J Hematol Oncol. 2018 Jun 20;11(1):85. doi: 10.1186/s13045-018-0623-3. J Hematol Oncol. 2018. PMID: 29925404 Free PMC article.
-
Cancer Stem Cells in Head and Neck Cutaneous Squamous Cell Carcinoma Express Cathepsins.Plast Reconstr Surg Glob Open. 2020 Aug 19;8(8):e3042. doi: 10.1097/GOX.0000000000003042. eCollection 2020 Aug. Plast Reconstr Surg Glob Open. 2020. PMID: 32983794 Free PMC article.
-
Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma.J Hematol Oncol. 2019 Dec 5;12(1):132. doi: 10.1186/s13045-019-0827-1. J Hematol Oncol. 2019. PMID: 31805962 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous